drugset / Trial / NCT06827431

The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression

NCT06827431

Phase 3 Not yet recruiting 770 enrolled CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Ammoxetine hydrochloride enteric-coated tablets in subjects with depression.

Timeline

Start
2025-02-14
Primary completion
2026-06-30
Completion
2026-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ammoxetine Unknown
Comparator Sertraline Small molecule